Integrity Continuing Education

 

 

Integrity Continuing Education
N

Advancing Care for Patients With SCLC

By Integrity Continuing Education FEATURING Narjust Florez, Estelamari Rodriguez, Cardinale Smith
By Integrity Continuing Education FEATURING Narjust Florez, Estelamari Rodriguez, Cardinale Smith
80 views
September 5, 2023
0 Comments
Login to view comments. Click here to Login
Oncology & Hematology
06:28
Integrity Continuing Education

TROP-2 ADCs for the Treatment of HR+/HER2- BC, TNBC, and NSCLC: Adva…

Feat. L. Schwartzberg, J. Porter
03:46
Integrity Continuing Education

The Evolving Treatment Journey for Patients With Unresectable Stage …

Feat. T. Leal
03:35
Integrity Continuing Education

Case Discussion: 59 y/o Former Smoker With Stage 3A NSCLC

Feat. T. Leal
02:35
Integrity Continuing Education

SABCS 2023 Summary: "monarchE & NATALEE Trials - Adjuvant T…

Feat. A. Bardia
03:06
Integrity Continuing Education

SABCS 2023 Insights: "KEYNOTE-756 Trial - Pembro vs. Placebo Co…

Feat. M. Lustberg
03:40
Integrity Continuing Education

SABCS 2023 Insights: "CAPItello-291 Trial - Capivasertib & …

Feat. A. Bardia
03:24
Integrity Continuing Education

SABCS 2023 Insights: "TROPION-Breast01 - Dato-DXd Compared to C…

Feat. A. Bardia
10:48
Integrity Continuing Education

Cervical Chronicles: Navigating the Evolving Landscape of Treatment

Feat. M. Murphy
05:52
Integrity Continuing Education

Expert Panel Case Discussion: Stage 4A High-Grade Serous Epithelial …

Feat. M. Murphy, E. Teplinsky, M. Finkel
05:55
Integrity Continuing Education

Expert Panel Case Discussion: 45 y/o With Recurrent Stage 3A Platinu…

Feat. M. Murphy, E. Teplinsky, M. Finkel
05:55
Integrity Continuing Education

Expert Panel Case Discussion: BRCA+ Epithelial Ovarian Cancer Who Ha…

Feat. M. Murphy, E. Teplinsky, M. Finkel
06:23
Integrity Continuing Education

ASH 2023 Insights: "PERSEUS Study - Daratumumab With VRd vs. VR…

Feat. O. Landgren
22:56
Integrity Continuing Education

Collaborative Care in MF - Community and Academic Physicians Discuss…

Feat. L. Fletcher, A. Gerds
07:37
Integrity Continuing Education

ASH 2023 Insights: "CARTITUDE-2 Updates - Cilta-Cel in Patients…

Feat. S. Usmani
04:09
Integrity Continuing Education

SABCS 2023 Summary: "Clinical Updates in HER2+ BC"

Feat. P. Tarantino
02:12
Integrity Continuing Education

Health Disparities in Endometrial Cancer

Feat. M. Murphy
04:18
Integrity Continuing Education

Advancing Care for Patients With SCLC

Feat. N. Florez, E. Rodriguez, C. Smith
06:14
Integrity Continuing Education

A Brief Review of Ongoing NSCLC Clinical Trials

Feat. J. Gainor, J. Sands
07:46
Integrity Continuing Education

40 y/o Male With Stage 3A NSCLC: Treatment Options

Feat. J. Gainor, J. Sands
04:31
Integrity Continuing Education

Neoadjuvant and Adjuvant Treatment in Early Stage NSCLC: Options Are…

Feat. J. Gainor, J. Sands
07:22
Integrity Continuing Education

Targeted Treatment of Myelofibrosis: Novel Pathways & Mechanisms…

Feat. R. Mesa, A. Gerds
07:27
Integrity Continuing Education

New Frontiers in the Targeted Treatment of Myelofibrosis: Second-Gen…

Feat. R. Mesa, A. Gerds